LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment
March 30, 2021
Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...
Equillium Inc.
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...